Abstract. In 1991 and 1992, a prenatal screening of Trypanosoma cruzi infection was carried out using ELISA and indirect immunofluorescence techniques. A total of 840 blood samples from pregnant women, obtained at the Maternity Ward of the Hospital de Clínicas, National University of Asunción (Asunción, Paraguay), and 1,022 samples from the Regional Hospital of the San Pedro Department of Paraguay were examined. It was observed that 7.7% and 10.5%, respectively, of the pregnant women were serologically positive for infection with T. cruzi. When blood samples obtained from newborns on the day of birth or, at the most, on the first few days afterwards were examined by direct microscopic observation, an incidence of congenital transmission of 3% was found. These results are consistent with those of neighboring countries. When a serologic follow-up was conducted on the newborns until six months of age, the incidence of congenital transmission reached 10%. The same incidence rate was obtained when the samples collected during the first days after birth were examined by the polymerase chain reaction (PCR). Fiftyeight infants born to seropositive mothers were followed-up, two of which were positive by direct microscopic observation at birth, and four who were PCR-positive, but microscopy-negative at birth. None of the infants were positive for IgM at birth. The infected babies were treated with benznidazole and were followed-up by serology and PCR for four years. We conclude that the PCR has a clear advantage over conventional techniques for the early detection of congenital transmission of T. cruzi infection, and for monitoring infants undergoing chemotherapy.
Chagas' disease, caused by the protozoan Trypanosoma cruzi, is a major public health problem in Latin America. According to a 1990 Pan American Health Organization report 1 , the prevalence of the disease in Paraguay is 400,000 infected people and the yearly incidence is 14,680 new cases. Based on the former data, we estimate that currently Paraguay has almost 600,000 individuals infected with T. cruzi, taking into account the birth rate (36.7/1,000/year), the migration rate to the urban areas, and the lack of fumigation campaigns from 1980 until 1993.
Most of the new cases of Chagas' disease occur during the early years of life, 2 and infants are the only patients amenable to specific treatment with greatest possibility of cure. 3, 4 It has been reported that benznidazole treatment of early chronic T. cruzi infection was safe and 55.8% effective in producing negative seroconversion of specific antibodies. 5 The infected pregnant mother can transmit the parasite both in the acute stage in which the parasitemia is high, as well as in the chronic stage, characterized by oligoparasitemia and in which the disease is usually asymptomatic. 6 The infected newborn may show a clinical picture characterized by prematurity, hepatomegaly, splenomegaly, jaundice, anemia, and alterations in the central nervous system, resulting in a high mortality rate. 2, 7 Only after six months of age does the persistence of anti-T. cruzi IgG antibodies in the infant's bloodstream becomes relevant in confirming T. cruzi infection. 8 This fact is particularly important from the diagnostic point of view, since although conventional parasitologic methods are highly sensitive in detecting neonatal infection, the number of parasites is often too low to be detected.
Several reports exist on the use of the polymerase chain reaction (PCR) for diagnosis of T. cruzi infection [9] [10] [11] [12] [13] and its advantage over parasitologic methods such as direct microscopic observation, 14 hemoculture, 15 and xenodiagnosis 16 because of its high sensitivity. 17 We have found that the PCR, when used with the T. cruzi-specific primers TCZ-1 and TCZ-2, which anneal to a highly repetitive sequence of T. cruzi nuclear DNA, 18 is far more sensitive than direct microscopic observation for the neonatal diagnosis of T. cruzi infection. 19 In this study, we used the PCR to detect T. cruzi infection in blood samples of newborns for early diagnosis and to monitor treatment.
PATIENTS, MATERIALS, AND METHODS
Patients. The method of treatment of patients selected for this study was approved by the Ethical Committee of the Instituto de Investigaciones en Ciencias de la Salud. During the prenatal period in the hospital, the women were informed about the risks of Chagas' disease for them and their babies and the objectives of this study. Only those who gave their consent were included in this study.
Pregnant women were recruited from 1991 to 1992 at the Maternity Ward of the Hospital de Clínicas (MHC), National University of Asunción, the capital city of Paraguay, located in the Central Department, and at the Hospital Regional of the San Pedro Department (HRSP), a rural town 400 km north of Asunción. Paraguay is a land-locked country located in central South America, whose urban population comprises 50.5% of the total population. Geographically, this country is organized into 19 departments; each department comprises several districts in which the towns are located. The areas highly endemic for T. cruzi infection have seroprevalences ranging between 20% and 30%. The areas included in the present studies have relatively low seroprevalences for Chagas' disease. Seropositive pregnant women were detected during a prenatal screening by an ELISA 20 for T. cruzi infection. Figure 1 summarizes the trial design and screening procedures for recruitment of pregnant women and newborns. To be eligible for the trial, pregnant women had to be seropositive by ELISA and indirect immunofluorescence (IIF). 20 Newborn treatment. Six PCR-positive babies were monitored and treatment with benznidazole (7 mg/kg of body weight was given in two daily doses for 60 days) was initiated the day T. cruzi infection was confirmed by direct microscopic observation. Blood samples were taken both during treatment and 5-46 months after completion of treatment. Permanent medical supervision was maintained during the treatment period by a physician from the nearest health care center.
Isolation of DNA from plasma. Plasma samples (100 l) were treated by addition of 250 l of 0.1 M NaCl, 10 mM Tris-HCl, pH 8.0, 1 mM EDTA, 50 l of 30% sarkosyl, and 1.5 l of proteinase K (20 mg/ml), and incubated at 60ЊC for 1 hr. The solution was extracted with phenol-chloroform and the DNA was precipitated by addition of 50 l of 3 M sodium acetate, pH 5.0, 20 g of glycogen, and two volumes of cold ethanol. After incubation at -80ЊC for 1 hr, the sample was centrifuged at 15,000 rpm for 20 min and the DNA pellet was suspended in 50 l of distilled water and stored at -20ЊC.
Amplification of T. cruzi DNA. The PCR was performed in a 50-l reaction mixture that contained one-tenth of the total DNA isolated, 250 mM of each deoxynucleotide triphosphate, 100 pmol of each primer and one unit of Tth polymerase (Toyobo Co., Ltd., Osaka, Japan). The reaction mixture was overlaid with 50 l of mineral oil and then subjected to 30 amplification cycles in a thermal cycler. The temperature and time profile for denaturation, primer annealing, and primer extension for the primers pair TCZ-1 and TCZ-2 have already been published. 19 The reaction products were electrophoresed in a gel containing 2.0% Nusieve GTG agarose (FMC Bioproducts, Rockland, ME) and 0.5% NA agarose (Pharmacia, Uppsala, Sweden) and the DNA bands were visualized by ethidium bromide fluorescence. Tables 1 and 2 , respectively. We found that 470 (56%) of the 840 pregnant women from the MHC included in the present study currently live in the Central Department, whereas 44% had been born in other Departments, most of them being rural areas. Among the latter, the highest percentage (11%) of infected women was found. Thus, the phenomenon of migration from endemic rural areas to the city is a potential important source of spread of the infection, both by congenital transmission and blood transfusion. The entire population of pregnant women tested by serologic analysis in the rural area (San Pedro Department) had lived only in this Department. The majority (59%) had lived only in the same district, and it is in this group that the highest positivity rate was encountered (12%). About one-third of the population (30%) had lived only in the same city, in which a low number (7%) of positive cases were found. These data suggest that the migration of infected people between different communities of the same department affects the epidemiology of T. cruzi infection.
RESULTS

Distribution of infected
Detection of T. cruzi infection in newborn babies. Infants born to seropositive chagasic mothers were examined for the congenital transmission of the disease. The newborn babies were examined for T. cruzi infection by direct microscopic observation, IIF for anti-T. cruzi IgM antibodies, and the PCR. At the MHC in Asunción, 65 samples of newborn babies born to seropositive mothers were analyzed on the day of birth, and two of them were positive by direct microscopic observation (3% congenital transmission); however, it was possible to follow-up only 28 (43%) of these 65 samples. Table 3 shows the results of the followed-up samples obtained from those babies congenitally infected with T. cruzi. Babies 1 and 2 were positive by direct microscopic observation at birth, and baby 3 was PCR-positive but microscopy-negative at birth. At the HRSP in San Pedro Department, it was possible to follow-up 30 samples of newborn babies from the 107 seropositive mothers (28%). Of these 30 samples obtained on the day of birth, none were microscopy-positive, but three were PCR-positive (10% congenital transmission), and the infections were confirmed at five and eight months of age by direct microscopic observation, and at 22 months of age by hemoculture, as shown in Table 3 (babies 4, 5, and 6, respectively).
Polymerase chain reaction-based detection of T. cruzi in congenital Chagas' disease. The amplified products of T. cruzi DNA detected in samples from babies 1, 3, and 4, by agarose gel electrophoresis and Southern blot hybridization analysis 21 have been previously reported. 19 It was possible to detect T. cruzi DNA in the plasma of six newborns on the day of birth. When parasitemia was detectable by conventional methods, the PCR products were clearly visible in the gel stained with ethidium bromide.
Follow-up treatment of congenitally infected babies. During follow-up, no side effects or toxicity was observed. Side effects were recorded through special attention given to clinical manifestations known to be associated with the use of benznidazole. The efficacy of benznidazole was assessed by the PCR, which is considered the parasitologic detection method with highest sensitivity in the chronic phase of the infection. [13] [14] [15] [16] [17] The results in Table 3 show that while the serology still remains positive after 3-8 months post-treatment, it is possible to evaluate the effectiveness of the treatment by the PCR, with higher sensitivity as soon as 15 days post-treatment (baby 1).
Serology versus the PCR. Of the 58 newborn babies, six (10%) were shown to be PCR-positive for T. cruzi infection in blood samples collected at birth. The results of the IIF test for anti-T. cruzi IgM antibodies were negative at birth in all samples, but were positive in these babies at eight and 22 months of age, in which case treatment was initiated too late (babies 5 and 6, respectively). DISCUSSION We have analyzed 840 samples obtained at the Maternity Ward of the Hospital de Clinicas in Asunción and 1,022 samples at the Hospital Regional in the San Pedro Department, where 7.7% and 10.5%, respectively, of the pregnant women were serologically positive for T. cruzi infection. When testing of the blood of infants born to infected mothers was performed on the day of birth, the incidence of transmission was 3%. This result is in agreement with previous reports from Paraguay, as well as from neighboring countries. 22 The incidence increased to 10% at the follow-up of the newborns (six positive babies of the 58 followed-up babies). We have observed that even with the great efforts invested in the project, we could not motivate both the general population and medical staff about the importance of early diagnosis in congenital Chagas' disease. This fact was demonstrated by the poor compliance of seropositive mothers for the follow-up of children with no parasitemia at birth: 43% at the Maternity Ward in Asunción and 30% at the Hospital de San Pedro. Therefore, a reliable and sensitive screening method for the detection of infected babies is needed.
Of the six infected newborns, only two were shown by direct microscopic observation to be carrying circulating parasites on the day of birth. The remaining four infected babies had circulating parasites (three demonstrated by direct microscopic observation and one by hemoculture) seen only afterwards during the course of follow-up. The serologic (anti-T. cruzi IgM by IIF and ELISA) methods failed to yield positive results, which may be due to an excess of passively transferred maternal IgG that suppresses the fetal synthesis of specific IgM and may give rise to false-negative results, as was previously observed. 23 Treatment was initiated the day confirmation of T. cruzi infection by conventional parasitologic methods was made, although the PCR results were already positive on the day of birth.
The infected newborns detected by direct microscopic observation at birth (babies 1 and 2), were treated immediately, but parasites still remained in the blood 8 and 12 days after treatment, respectively, because of incorrect administration of the drug. In both cases, the correct treatment was initiated, and negative seroconversion (disappearance of anti-T. cruzi IgG) was observed after three months of age. This result was expected because maternal antibodies present in the newborns and early treatment precluded production of specific antibodies by these babies. Babies 3, 4, 5, and 6 were treated at three, five, eight, and 22 months of age, respectively. Negative seroconversion was observed as soon as two months post-treatment (baby 3). These results suggest that the later the treatment is initiated, as in baby 6, the later the negative seroconversion takes place (eight months post-treatment).
We conclude that conventional parasitologic and serologic techniques are not efficient enough to provide early diagnosis of congenital Chagas' disease, especially in rural areas, where Chagas' disease is endemic. These data suggest that the rate of congenital transmission may be underestimated since there is minimal follow-up of neonates from birth to six months of age, although parasite clearance is more rapidly assessed by the PCR than by serologic methods. This ensures an earlier effective treatment, rather than waiting for negative seroconversion.
